ArticleCancer research2025

Tumor-Derived CCL16 Normalizes Tumor Vasculature through Macrophage ICAM-1 Receptor and Enhances Immunotherapy Efficacy in Hepatocellular Carcinoma.

Kunling Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.